Skip to main content
main-content

Virtual EASD Annual Meeting 2020

21 – 25 September

COVID-19 and diabetes: The current evidence

Juliana Chan

Juliana Chan outlines current knowledge about the relationship between diabetes and COVID-19, discussing risk factors for poor outcomes in people with both conditions and the need for collaborative efforts to improve patient care (7:09).

EASD 2020 research news

09-23-2020 | EASD 2020 | Conference coverage | News

Type 2 diabetes screening underperformed in women with gestational diabetes

Less than half of women with gestational diabetes undergo a guideline-recommended test for type 2 diabetes within 12 weeks of delivery, show results presented in a poster at the virtual 56th EASD Annual Meeting.

09-23-2020 | EASD 2020 | Conference coverage | News

Polypharmacy linked to adverse outcomes in people with type 1 diabetes

Study findings presented at the virtual 56th EASD Annual Meeting indicate that polypharmacy is common among people with type 1 diabetes and is associated with an increased risk for adverse outcomes.

09-23-2020 | EASD 2020 | Conference coverage | News

Novel oral insulin shows promise for type 2 diabetes

The novel oral insulin ORMD-0801 warrants further investigation as a treatment option for patients with inadequately controlled type 2 diabetes, indicate findings from a phase 2b trial presented at the virtual 56th EASD Annual Meeting.

Upcoming interviews

Hiddo Heerspink discusses the DAPA-CKD trial


The Editorial Board is on-hand to help you plan which sessions to attend. 

Browse their selections below by swiping horizontally or by using the < > arrows.

Sign up to the Medicine Matters diabetes

Keep up-to-date with breaking news from EASD 2020.

Sign up to the Medicine Matters diabetes e-alert to receive all the latest news, research and exclusive expert interviews straight to your inbox.

* indicates required
Are you a healthcare professional? *
Image Credits